What are biosimilar products, and why are they important to the health care and patient communities? Learn more with Leah Christl, Ph.D., Associate Director for Therapeutic Biologics and lead of the Office of New Drugs (OND) Therapeutic Biologics and Biosimilars staff at FDA CDER. For more information, visit [ Ссылка ] .
